Transendothelial migration of neutrophils involves integrin-associated protein (CD47) - PubMed (original) (raw)
Comparative Study
Transendothelial migration of neutrophils involves integrin-associated protein (CD47)
D Cooper et al. Proc Natl Acad Sci U S A. 1995.
Abstract
Inflammation is a primary pathological process. The development of an inflammatory reaction involves the movement of white blood cells through the endothelial lining of blood vessels into tissues. This process of transendothelial cell migration of neutrophils has been shown to involve neutrophil beta 2 integrins (CD18) and endothelial cell platelet-endothelium cell adhesion molecules (PECAM-1; CD31). We now show that F(ab')2 fragments of the monoclonal antibody B6H12 against integrin-associated protein (IAP) blocks the transendothelial migration of neutrophils stimulated by an exogenous gradient of the chemokine interleukin 8 (IL-8; 60% inhibition), by the chemotactic peptide N-formyl-methionylleucylphenylalanine (FMLP; 76% inhibition), or by the activation of the endothelium by the cytokine tumor necrosis factor alpha (98% inhibition). The antibody has two mechanisms of action: on neutrophils it prevents the chemotactic response to IL-8 and FMLP, and on endothelium it prevents an unknown but IL-8-independent process. Blocking antibodies to IAP do not alter the expression of adhesion proteins or production of IL-8 by endothelial cells, and thus the inhibition of neutrophil transendothelial migration is selective. These data implicate IAP as the third molecule essential for neutrophil migration through endothelium into sites of inflammation.
Similar articles
- L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin.
Simon SI, Burns AR, Taylor AD, Gopalan PK, Lynam EB, Sklar LA, Smith CW. Simon SI, et al. J Immunol. 1995 Aug 1;155(3):1502-14. J Immunol. 1995. PMID: 7543524 - Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo.
Thompson RD, Wakelin MW, Larbi KY, Dewar A, Asimakopoulos G, Horton MA, Nakada MT, Nourshargh S. Thompson RD, et al. J Immunol. 2000 Jul 1;165(1):426-34. doi: 10.4049/jimmunol.165.1.426. J Immunol. 2000. PMID: 10861081 - A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration.
Kubes P, Niu XF, Smith CW, Kehrli ME Jr, Reinhardt PH, Woodman RC. Kubes P, et al. FASEB J. 1995 Aug;9(11):1103-11. FASEB J. 1995. PMID: 7544310 - Adhesion molecules mediating neutrophil migration to arthritis in vivo and across endothelium and connective tissue barriers in vitro.
Issekutz AC. Issekutz AC. Inflamm Res. 1998 Oct;47 Suppl 3:S123-32. doi: 10.1007/s000110050300. Inflamm Res. 1998. PMID: 9831314 Review. - Transendothelial migration.
Smith CW. Smith CW. Curr Top Microbiol Immunol. 1993;184:201-12. doi: 10.1007/978-3-642-78253-4_16. Curr Top Microbiol Immunol. 1993. PMID: 7906215 Review. No abstract available.
Cited by
- Cell autonomous functions of CD47 in regulating cellular plasticity and metabolic plasticity.
Polara R, Ganesan R, Pitson SM, Robinson N. Polara R, et al. Cell Death Differ. 2024 Oct;31(10):1255-1266. doi: 10.1038/s41418-024-01347-w. Epub 2024 Jul 23. Cell Death Differ. 2024. PMID: 39039207 Free PMC article. Review. - Tolerating CD47.
Isenberg JS, Montero E. Isenberg JS, et al. Clin Transl Med. 2024 Feb;14(2):e1584. doi: 10.1002/ctm2.1584. Clin Transl Med. 2024. PMID: 38362603 Free PMC article. Review. - CD47 expression is critical for CAR T-cell survival in vivo.
Beckett AN, Chockley P, Pruett-Miller SM, Nguyen P, Vogel P, Sheppard H, Krenciute G, Gottschalk S, DeRenzo C. Beckett AN, et al. J Immunother Cancer. 2023 Mar;11(3):e005857. doi: 10.1136/jitc-2022-005857. J Immunother Cancer. 2023. PMID: 36918226 Free PMC article. - CD47 as a promising therapeutic target in oncology.
Zhao H, Song S, Ma J, Yan Z, Xie H, Feng Y, Che S. Zhao H, et al. Front Immunol. 2022 Aug 22;13:757480. doi: 10.3389/fimmu.2022.757480. eCollection 2022. Front Immunol. 2022. PMID: 36081498 Free PMC article. Review. - Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.
Behrens LM, van den Berg TK, van Egmond M. Behrens LM, et al. Cancers (Basel). 2022 Jul 11;14(14):3366. doi: 10.3390/cancers14143366. Cancers (Basel). 2022. PMID: 35884427 Free PMC article. Review.
References
- J Cell Biol. 1989 May;108(5):1935-43 - PubMed
- EMBO J. 1989 Dec 1;8(12):3759-65 - PubMed
- Science. 1993 Dec 3;262(5139):1580-2 - PubMed
- Blood. 1990 Mar 1;75(5):1037-50 - PubMed
- Blood. 1990 Jan 1;75(1):227-37 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous